Use of on-therapy ctDNA monitoring in a patient with KIF5B-RET fusion positive advanced non-small cell lung cancer: a case report

Molecular characterization of non-small cell lung cancer (NSCLC) has led to marked improvements in the treatment of patients with advanced disease who harbor driver mutations, including those with alterations in the RET proto-oncogene. Liquid biopsy to detect circulating tumor DNA (ctDNA) is a clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Vincent, Kim, Chul, Kiedrowski, Lesli A., Liu, Stephen V., Reuss, Joshua E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825655/
https://www.ncbi.nlm.nih.gov/pubmed/35242632
http://dx.doi.org/10.21037/tlcr-21-571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825655/
https://www.ncbi.nlm.nih.gov/pubmed/35242632
http://dx.doi.org/10.21037/tlcr-21-571

Ejemplares similares